| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |